Semler Scientific (SMLR) Competitors $39.54 +4.12 (+11.63%) Closing price 04:00 PM EasternExtended Trading$39.35 -0.19 (-0.47%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMLR vs. TNDM, SSII, CDRE, AORT, LQDA, FNA, ESTA, PLSE, BLFS, and MDXGShould you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Tandem Diabetes Care (TNDM), SS Innovations International (SSII), Cadre (CDRE), Artivion (AORT), Liquidia Technologies (LQDA), Paragon 28 (FNA), Establishment Labs (ESTA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), and MiMedx Group (MDXG). These companies are all part of the "medical equipment" industry. Semler Scientific vs. Its Competitors Tandem Diabetes Care SS Innovations International Cadre Artivion Liquidia Technologies Paragon 28 Establishment Labs Pulse Biosciences BioLife Solutions MiMedx Group Semler Scientific (NASDAQ:SMLR) and Tandem Diabetes Care (NASDAQ:TNDM) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Which has more volatility and risk, SMLR or TNDM? Semler Scientific has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.48, suggesting that its share price is 48% more volatile than the S&P 500. Do analysts prefer SMLR or TNDM? Semler Scientific presently has a consensus price target of $71.00, indicating a potential upside of 79.56%. Tandem Diabetes Care has a consensus price target of $33.43, indicating a potential upside of 95.72%. Given Tandem Diabetes Care's higher probable upside, analysts clearly believe Tandem Diabetes Care is more favorable than Semler Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Tandem Diabetes Care 0 Sell rating(s) 9 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.40 Do institutionals and insiders believe in SMLR or TNDM? 49.4% of Semler Scientific shares are held by institutional investors. 30.2% of Semler Scientific shares are held by company insiders. Comparatively, 1.9% of Tandem Diabetes Care shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has preferable earnings & valuation, SMLR or TNDM? Semler Scientific has higher earnings, but lower revenue than Tandem Diabetes Care. Semler Scientific is trading at a lower price-to-earnings ratio than Tandem Diabetes Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSemler Scientific$56.29M7.83$40.90M-$2.61-15.15Tandem Diabetes Care$940.20M1.21-$96.03M-$2.78-6.14 Does the media refer more to SMLR or TNDM? In the previous week, Tandem Diabetes Care had 3 more articles in the media than Semler Scientific. MarketBeat recorded 9 mentions for Tandem Diabetes Care and 6 mentions for Semler Scientific. Tandem Diabetes Care's average media sentiment score of 1.19 beat Semler Scientific's score of 0.19 indicating that Tandem Diabetes Care is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Semler Scientific 0 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tandem Diabetes Care 3 Very Positive mention(s) 5 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is SMLR or TNDM more profitable? Tandem Diabetes Care has a net margin of -18.71% compared to Semler Scientific's net margin of -60.69%. Semler Scientific's return on equity of 19.75% beat Tandem Diabetes Care's return on equity.Company Net Margins Return on Equity Return on Assets Semler Scientific-60.69% 19.75% 15.47% Tandem Diabetes Care -18.71%-57.33%-13.48% SummarySemler Scientific and Tandem Diabetes Care tied by winning 8 of the 16 factors compared between the two stocks. Get Semler Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMLR vs. The Competition Export to ExcelMetricSemler ScientificMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$394.99M$6.89B$5.54B$8.87BDividend YieldN/A1.16%5.39%4.10%P/E Ratio-15.1526.5426.1419.88Price / Sales7.8395.96414.67113.66Price / Cash7.9121.0136.1356.90Price / Book1.594.718.055.38Net Income$40.90M$173.18M$3.15B$248.50M7 Day Performance-3.65%1.45%1.85%2.97%1 Month Performance11.10%0.27%4.81%6.02%1 Year Performance20.73%29.02%34.86%20.39% Semler Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMLRSemler Scientific2.2992 of 5 stars$39.54+11.6%$71.00+79.6%+5.0%$394.99M$56.29M-15.15120Gap UpTNDMTandem Diabetes Care4.2138 of 5 stars$20.22flat$33.43+65.3%-56.3%$1.35B$940.20M-7.272,650Positive NewsSSIISS Innovations InternationalN/A$5.65-18.4%N/AN/A$1.34B$22.13M0.004Gap DownCDRECadre3.6765 of 5 stars$32.76-0.3%$37.50+14.5%-3.9%$1.34B$567.56M34.482,284AORTArtivion2.6265 of 5 stars$30.84+1.9%$32.00+3.8%+20.7%$1.29B$388.54M-61.671,600Positive NewsLQDALiquidia Technologies3.3726 of 5 stars$13.26+0.7%$26.89+102.8%-0.3%$1.13B$14M-8.3950Positive NewsFNAParagon 280.4962 of 5 stars$13.11+0.1%$12.75-2.7%+99.5%$1.10B$256.18M-17.71343,000High Trading VolumeESTAEstablishment Labs1.2754 of 5 stars$36.58-3.3%$52.40+43.2%+0.1%$1.09B$166.02M-11.801,018PLSEPulse Biosciences1.3697 of 5 stars$15.49+1.2%N/A+37.0%$1.03B$700K0.00140BLFSBioLife Solutions3.0716 of 5 stars$21.36+0.7%$31.17+45.9%+4.2%$1.01B$82.25M-73.65440Positive NewsMDXGMiMedx Group3.7419 of 5 stars$5.94+2.2%$12.50+110.4%-7.2%$858.15M$348.88M22.00870 Related Companies and Tools Related Companies Tandem Diabetes Care Alternatives SS Innovations International Alternatives Cadre Alternatives Artivion Alternatives Liquidia Technologies Alternatives Paragon 28 Alternatives Establishment Labs Alternatives Pulse Biosciences Alternatives BioLife Solutions Alternatives MiMedx Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMLR) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semler Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semler Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
